Congenital heart disease
-
Congenital heart disease · May 2009
Case ReportsExceptional survival: double inlet left ventricle with pulmonary artery banding.
This is a case of a patient with a univentricular heart and transposition of the great arteries who was treated with a pulmonary artery banding as a child. We describe his clinical course and crucial factors associated with his prolonged survival.
-
Congenital heart disease · May 2009
Do neonates with genetic abnormalities have an increased morbidity and mortality following cardiac surgery?
Genetic abnormalities occur in approximately 20% of children with congenital heart disease. The purpose of this study was to evaluate the effect of genetic abnormalities on short-term outcomes following neonatal cardiac surgery. ⋯ Neonates with genetic abnormalities have a higher risk of postoperative complications and a longer hospital length of stay. However, there is no increase in hospital mortality. This information may aid in patient management decisions and parental counseling. Longer-term studies are needed for understanding the total impact of genetic abnormalities on neonates with congenital heart disease.
-
Congenital heart disease · Jan 2009
Case ReportsTetralogy of Fallot with anomalous systemic and pulmonary venous drainage, anomalous coronary artery pattern, and abnormal development of diaphragm.
We report a patient with tetralogy of Fallot, total anomalous pulmonary venous return to the right atrium, large atrial septal defect, anomalous course and termination of the superior vena cava, anomalous origin and course of the right coronary artery, and a defect in the diaphragm. This interesting combination of anomalies was managed successfully.
-
Congenital heart disease · Jan 2009
Surgical closure of patent ductus arteriosus in preterm low birth weight infants.
In many preterm low-birth-weight infants, ductus arteriosus fails to close spontaneously. This study evaluates the results of surgical ligation of symptomatic patent ductus arteriosus (PDA) in preterm low birth weight infants. ⋯ We conclude that surgical closure of hemodynamically significant PDA is safe and effective in preterm low birth weight infants when pharmacological treatment is ineffective or contraindicated. The associated morbidity is minimal and no surgery-related mortality was observed.
-
Congenital heart disease · Jul 2008
Case ReportsArgatroban anticoagulation for cardiac surgery with cardiopulmonary bypass in an infant with double outlet right ventricle and a history of heparin-induced thrombocytopenia.
Heparin-induced thrombocytopenia (HIT) is a life-threatening complication of heparin therapy. Anticoagulation in pediatric patients with HIT is challenging as there are no approved heparin substitutes. We report the use of the anticoagulant argatroban for cardiac surgery with cardiopulmonary bypass in an infant with double outlet right ventricle and a history of HIT.